Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Esperion Therapeutics, Inc. (ESPR) since 2015 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Esperion Therapeutics, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1434868.
Total stock buying since 2015: $56,203,594.
Total stock sales since 2015: $167,291,654.
Total stock option exercises since 2015: $1,620,516.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 0 | $0 | 65,017 | $80,413 | 0 | $0 |
| 2024 | 0 | $0 | 36,816 | $78,966 | 0 | $0 |
| 2023 | 59,611 | $86,146 | 30,004 | $98,772 | 0 | $0 |
| 2022 | 24,606 | $141,949 | 14,804 | $90,878 | 0 | $0 |
| 2021 | 530,000 | $10,744,049 | 0 | $0 | 0 | $0 |
| 2020 | 227,500 | $6,457,100 | 0 | $0 | 10,700 | $22,427 |
| 2019 | 372,500 | $14,960,966 | 48,329 | $2,285,935 | 0 | $0 |
| 2018 | 570,000 | $23,332,580 | 186,674 | $10,846,886 | 212,564 | $1,518,647 |
| 2017 | 1,000 | $42,260 | 1,159,326 | $50,116,192 | 21,471 | $79,442 |
| 2016 | 32,800 | $438,544 | 0 | $0 | 0 | $0 |
| 2015 | 0 | $0 | 934,938 | $103,693,612 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2025-07 | 0 | $0 | 1,315 | $1,481 | 0 | $0 |
| 2025-06 | 0 | $0 | 44,125 | $49,520 | 0 | $0 |
| 2025-04 | 0 | $0 | 180 | $168 | 0 | $0 |
| 2025-03 | 0 | $0 | 19,015 | $28,481 | 0 | $0 |
| 2025-02 | 0 | $0 | 250 | $466 | 0 | $0 |
| 2025-01 | 0 | $0 | 132 | $297 | 0 | $0 |
| 2024-12 | 0 | $0 | 17,926 | $43,985 | 0 | $0 |
| 2024-11 | 0 | $0 | 197 | $426 | 0 | $0 |
| 2024-10 | 0 | $0 | 107 | $226 | 0 | $0 |
| 2024-09 | 0 | $0 | 17,158 | $30,781 | 0 | $0 |
| 2024-08 | 0 | $0 | 211 | $410 | 0 | $0 |
| 2024-07 | 0 | $0 | 1,025 | $2,662 | 0 | $0 |
| 2024-05 | 0 | $0 | 192 | $476 | 0 | $0 |
| 2023-09 | 0 | $0 | 742 | $923 | 0 | $0 |
| 2023-08 | 0 | $0 | 243 | $343 | 0 | $0 |
| 2023-07 | 0 | $0 | 106 | $168 | 0 | $0 |
| 2023-06 | 0 | $0 | 603 | $894 | 0 | $0 |
| 2023-05 | 59,611 | $86,146 | 219 | $355 | 0 | $0 |
| 2023-04 | 0 | $0 | 2,343 | $2,978 | 0 | $0 |
| 2023-03 | 0 | $0 | 25,748 | $93,111 | 0 | $0 |
| 2022-10 | 0 | $0 | 1,049 | $8,064 | 0 | $0 |
| 2022-09 | 0 | $0 | 3,649 | $25,311 | 0 | $0 |
| 2022-08 | 9,606 | $57,409 | 199 | $1,356 | 0 | $0 |
| 2022-07 | 0 | $0 | 4,332 | $28,387 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-07-17 | Halladay Benjamin (Chief Financial Officer) | Sale | 11 | 1.11 | 12 |
| 2025-07-17 | Looker Benjamin (General Counsel) | Sale | 1,304 | 1.13 | 1,469 |
| 2025-06-17 | Halladay Benjamin (Chief Financial Officer) | Sale | 7,229 | 1.15 | 8,327 |
| 2025-06-17 | Looker Benjamin (General Counsel) | Sale | 6,422 | 1.15 | 7,398 |
| 2025-06-17 | Koenig Sheldon L. (President and CEO) | Sale | 30,474 | 1.11 | 33,795 |
| 2025-04-17 | Halladay Benjamin (Chief Financial Officer) | Sale | 40 | .96 | 35 |
| 2025-04-17 | Warren Eric (Chief Commercial Officer) | Sale | 108 | .98 | 105 |
| 2025-03-18 | Halladay Benjamin (Chief Financial Officer) | Sale | 3,535 | 1.48 | 5,242 |
| 2025-03-18 | Warren Eric (Chief Commercial Officer) | Sale | 2,433 | 1.49 | 3,617 |
| 2025-03-18 | Koenig Sheldon L. (President and CEO) | Sale | 13,047 | 1.50 | 19,622 |
| 2025-02-19 | Halladay Benjamin (Chief Financial Officer) | Sale | 11 | 1.86 | 20 |
| 2025-02-19 | Warren Eric (Chief Commercial Officer) | Sale | 239 | 1.87 | 446 |
| 2025-01-17 | Halladay Benjamin (Chief Financial Officer) | Sale | 9 | 2.27 | 20 |
| 2025-01-17 | Warren Eric (Chief Commercial Officer) | Sale | 123 | 2.26 | 277 |
| 2024-12-17 | Halladay Benjamin (Chief Financial Officer) | Sale | 3,245 | 2.42 | 7,865 |
| 2024-12-17 | Warren Eric (Chief Commercial Officer) | Sale | 2,234 | 2.43 | 5,426 |
| 2024-12-17 | Koenig Sheldon L. (President and CEO) | Sale | 12,447 | 2.47 | 30,694 |
| 2024-11-19 | Warren Eric (Chief Commercial Officer) | Sale | 197 | 2.17 | 426 |
| 2024-10-17 | Warren Eric (Chief Commercial Officer) | Sale | 107 | 2.12 | 226 |
| 2024-09-17 | Warren Eric (Chief Commercial Officer) | Sale | 2,608 | 1.78 | 4,650 |
| 2024-09-17 | Koenig Sheldon L. (President and CEO) | Sale | 14,550 | 1.80 | 26,131 |
| 2024-08-19 | Warren Eric (Chief Commercial Officer) | Sale | 211 | 1.95 | 410 |
| 2024-07-17 | Warren Eric (Chief Commercial Officer) | Sale | 108 | 2.59 | 279 |
| 2024-07-17 | Foody Joanne M. (Chief Medical Officer) | Sale | 917 | 2.60 | 2,383 |
| 2024-05-17 | Warren Eric (Chief Commercial Officer) | Sale | 192 | 2.48 | 476 |
| 2023-09-20 | Warren Eric (Chief Commercial Officer) | Sale | 742 | 1.25 | 923 |
| 2023-08-18 | Warren Eric (Chief Commercial Officer) | Sale | 243 | 1.41 | 343 |
| 2023-07-19 | Warren Eric (Chief Commercial Officer) | Sale | 106 | 1.58 | 168 |
| 2023-06-21 | Warren Eric (Chief Commercial Officer) | Sale | 603 | 1.48 | 894 |
| 2023-05-17 | Warren Eric (Chief Commercial Officer) | Sale | 219 | 1.62 | 355 |
| 2023-05-11 | Carroll J Martin | Buy | 23,091 | 1.57 | 36,275 |
| 2023-05-10 | Carroll J Martin | Buy | 8,409 | 1.49 | 12,546 |
| 2023-05-10 | Rocamboli Stephen | Buy | 8,111 | 1.50 | 12,125 |
| 2023-05-09 | Koenig Sheldon L. (President and CEO) | Buy | 20,000 | 1.26 | 25,200 |
| 2023-04-19 | Warren Eric (Chief Commercial Officer) | Sale | 115 | 1.28 | 146 |
| 2023-04-19 | Foody Joanne M. (Chief Medical Officer) | Sale | 938 | 1.27 | 1,192 |
| 2023-04-19 | Looker Benjamin (General Counsel) | Sale | 1,290 | 1.27 | 1,640 |
| 2023-03-17 | Warren Eric (Chief Commercial Officer) | Sale | 526 | 1.78 | 937 |
| 2023-03-17 | Foody Joanne M. (Chief Medical Officer) | Sale | 3,808 | 1.78 | 6,785 |
| 2023-03-17 | Koenig Sheldon L. (President and CEO) | Sale | 6,999 | 1.78 | 12,479 |
| 2023-03-07 | Warren Eric (Chief Commercial Officer) | Sale | 5,090 | 5.05 | 25,729 |
| 2023-03-07 | Foody Joanne M. (Chief Medical Officer) | Sale | 3,884 | 5.07 | 19,672 |
| 2023-03-07 | Koenig Sheldon L. (President and CEO) | Sale | 5,441 | 5.06 | 27,509 |
| 2022-10-18 | Warren Eric (Chief Commercial Officer) | Sale | 107 | 7.69 | 822 |
| 2022-10-18 | Foody Joanne M. (Chief Medical Officer) | Sale | 942 | 7.69 | 7,242 |
| 2022-09-19 | Warren Eric (Chief Commercial Officer) | Sale | 255 | 6.92 | 1,764 |
| 2022-09-19 | Koenig Sheldon L. (President and CEO) | Sale | 3,394 | 6.94 | 23,547 |
| 2022-08-31 | Warren Eric (Chief Commercial Officer) | Buy | 1,000 | 7.46 | 7,460 |
| 2022-08-17 | Warren Eric (Chief Commercial Officer) | Sale | 199 | 6.82 | 1,356 |
| 2022-08-05 | Koenig Sheldon L. (President and CEO) | Buy | 8,606 | 5.80 | 49,949 |
| 2022-07-19 | Warren Eric (Chief Commercial Officer) | Sale | 431 | 6.58 | 2,836 |
| 2022-07-19 | Foody Joanne M. (Chief Medical Officer) | Sale | 3,901 | 6.55 | 25,551 |
| 2022-06-17 | Warren Eric (Chief Commercial Officer) | Sale | 256 | 4.90 | 1,254 |
| 2022-06-17 | Koenig Sheldon L. (President and CEO) | Sale | 4,552 | 4.99 | 22,719 |
| 2022-06-02 | Carroll J Martin | Buy | 10,000 | 5.64 | 56,360 |
| 2022-05-17 | Warren Eric (Chief Commercial Officer) | Sale | 196 | 5.98 | 1,172 |
| 2022-03-17 | Koenig Sheldon L. (President and CEO) | Sale | 571 | 4.58 | 2,615 |
| 2021-05-24 | Bb Biotech Ag (10% Owner) | Buy | 100,000 | 20.22 | 2,021,600 |
| 2021-05-19 | Bb Biotech Ag (10% Owner) | Buy | 200,000 | 20.37 | 4,074,000 |
| 2021-05-06 | Bb Biotech Ag (10% Owner) | Buy | 80,000 | 20.57 | 1,645,600 |
| 2021-05-05 | Bb Biotech Ag (10% Owner) | Buy | 150,000 | 20.02 | 3,002,849 |
| 2020-12-30 | Mayleben Timothy M (President & CEO) | Option Ex | 10,700 | 2.10 | 22,427 |
| 2020-11-03 | Bb Biotech Ag (10% Owner) | Buy | 200,000 | 25.31 | 5,062,200 |
| 2020-03-11 | Mayleben Timothy M (President & CEO) | Buy | 2,500 | 43.00 | 107,500 |
| 2020-02-28 | Mayleben Timothy M (President & CEO) | Buy | 5,000 | 49.00 | 245,000 |
| 2020-01-23 | Bb Biotech Ag (10% Owner) | Buy | 20,000 | 52.12 | 1,042,400 |
| 2019-11-06 | Mayleben Timothy M (President & CEO) | Buy | 5,000 | 36.98 | 184,899 |
| 2019-11-06 | Bb Biotech Ag (10% Owner) | Buy | 75,000 | 37.30 | 2,797,575 |
| 2019-09-06 | Mayleben Timothy M (President & CEO) | Buy | 2,500 | 35.25 | 88,125 |
| 2019-09-04 | Mayleben Timothy M (President & CEO) | Buy | 5,000 | 33.82 | 169,100 |
| 2019-09-04 | Bb Biotech Ag (10% Owner) | Buy | 80,000 | 33.78 | 2,702,240 |
| 2019-08-01 | Mayleben Timothy M (President & CEO) | Buy | 5,000 | 39.56 | 197,800 |
| 2019-07-23 | Bb Biotech Ag (10% Owner) | Buy | 50,000 | 42.65 | 2,132,550 |
| 2019-06-28 | Mayleben Timothy M (President & CEO) | Buy | 5,000 | 46.00 | 230,000 |
| 2019-04-03 | Bartram Richard (Chief Financial Officer) | Sale | 8,000 | 43.16 | 345,320 |
| 2019-03-29 | Mayleben Timothy M (President & CEO) | Buy | 5,000 | 40.00 | 200,000 |
| 2019-03-20 | Mayleben Timothy M (President & CEO) | Buy | 5,000 | 43.48 | 217,399 |
| 2019-03-19 | Vitullo Nicole (Director) | Sale | 15,329 | 44.95 | 689,115 |
| 2019-03-14 | Mayleben Timothy M (President & CEO) | Buy | 5,000 | 48.73 | 243,649 |
| 2019-03-14 | Bb Biotech Ag (10% Owner) | Buy | 50,000 | 49.89 | 2,494,350 |
| 2019-03-12 | Newton Roger S | Sale | 25,000 | 50.06 | 1,251,500 |
| 2019-01-04 | Bb Biotech Ag (10% Owner) | Buy | 80,000 | 41.29 | 3,303,279 |
| 2018-12-24 | Bb Biotech Ag (10% Owner) | Buy | 50,000 | 39.91 | 1,995,750 |
| 2018-12-17 | Bb Biotech Ag (10% Owner) | Buy | 60,000 | 47.73 | 2,864,100 |
| 2018-11-05 | Lewis Joseph (10% Owner) | Sale | 60,000 | 57.89 | 3,473,580 |
| 2018-11-02 | Newton Roger S | Sale | 227 | 50.76 | 11,522 |
| 2018-11-02 | Lewis Joseph (10% Owner) | Sale | 40,000 | 54.95 | 2,198,000 |
| 2018-11-01 | Newton Roger S | Sale | 2,600 | 50.01 | 130,026 |
| 2018-10-18 | Newton Roger S | Sale | 100 | 50.00 | 5,000 |
| 2018-10-17 | Newton Roger S | Sale | 12,673 | 50.02 | 633,903 |
| 2018-10-16 | Newton Roger S | Sale | 9,400 | 50.01 | 470,094 |
| 2018-08-27 | Newton Roger S | Sale | 17,700 | 52.17 | 923,497 |
| 2018-08-17 | Newton Roger S | Sale | 7,300 | 50.06 | 365,438 |
| 2018-08-03 | Bb Biotech Ag (10% Owner) | Buy | 50,000 | 46.14 | 2,306,950 |
| 2018-07-12 | Bb Biotech Ag (10% Owner) | Buy | 50,000 | 41.77 | 2,088,300 |
| 2018-06-29 | Bb Biotech Ag (10% Owner) | Buy | 50,000 | 39.48 | 1,973,800 |
| 2018-06-21 | Bb Biotech Ag (10% Owner) | Buy | 60,000 | 38.57 | 2,314,200 |
| 2018-06-07 | Bb Biotech Ag (10% Owner) | Buy | 60,000 | 37.79 | 2,267,280 |
| 2018-06-06 | Goldstein Dov A Md | Option Ex | 13,000 | 16.09 | 209,105 |
| 2018-06-05 | Bb Biotech Ag (10% Owner) | Buy | 60,000 | 38.47 | 2,308,440 |
| 2018-05-21 | Bb Biotech Ag (10% Owner) | Buy | 80,000 | 38.77 | 3,101,760 |
| 2018-05-18 | Bb Biotech Ag (10% Owner) | Buy | 50,000 | 42.24 | 2,112,000 |
| 2018-03-29 | Newton Roger S | Sale | 25,000 | 71.91 | 1,797,750 |
| 2018-02-07 | Newton Roger S | Option Ex | 34,651 | 6.99 | 242,210 |
| 2018-01-31 | Mayleben Timothy M (President & CEO) | Option Ex | 4,549 | 1.16 | 5,254 |
| 2018-01-25 | Vitullo Nicole (Director) | Sale | 11,674 | 71.79 | 838,076 |
| 2018-01-24 | Vitullo Nicole (Director) | Option Ex | 71,235 | 6.99 | 497,932 |
| 2018-01-18 | Janney Daniel (Director) | Option Ex | 71,237 | 6.99 | 497,946 |
| 2018-01-02 | Bartram Richard (Chief Financial Officer) | Option Ex | 17,892 | 3.70 | 66,200 |
| 2017-12-18 | Goldstein Dov A Md | Option Ex | 21,471 | 3.70 | 79,442 |
| 2017-12-06 | Vitullo Nicole (Director) | Sale | 9,326 | 53.85 | 502,205 |
| 2017-03-22 | Goldstein Dov A Md | Sale | 312,642 | 38.82 | 12,136,762 |
| 2017-03-21 | Janney Daniel (Director) | Sale | 350,000 | 46.53 | 16,286,900 |
| 2017-03-21 | Omenn Gilbert S (Director) | Buy | 1,000 | 42.26 | 42,260 |
| 2017-03-21 | Goldstein Dov A Md | Sale | 487,358 | 43.48 | 21,190,325 |
| 2016-11-01 | Lalwani Narendra D. (Chief Operating Officer) | Buy | 5,000 | 9.93 | 49,650 |
| 2016-07-06 | Mcgovern Mark E | Buy | 4,400 | 10.00 | 44,000 |
| 2016-07-05 | Mcgovern Mark E | Buy | 600 | 10.00 | 6,000 |
| 2016-05-04 | Mayleben Timothy M (President & CEO) | Buy | 7,000 | 14.85 | 103,950 |
| 2016-03-01 | Omenn Gilbert S | Buy | 5,000 | 15.28 | 76,400 |
| 2016-01-27 | Mayleben Timothy M (President & CEO) | Buy | 3,600 | 15.88 | 57,168 |
| 2016-01-15 | Mayleben Timothy M (President & CEO) | Buy | 7,200 | 14.08 | 101,376 |
| 2015-04-24 | Elms Steve | Sale | 67,469 | 107.05 | 7,222,556 |
| 2015-04-24 | Goldstein Dov A Md | Sale | 67,469 | 107.05 | 7,222,556 |
| 2015-04-23 | Elms Steve | Sale | 150,000 | 109.10 | 16,365,000 |
| 2015-04-23 | Goldstein Dov A Md | Sale | 150,000 | 109.10 | 16,365,000 |
| 2015-03-19 | Enright Patrick G | Sale | 500,000 | 113.04 | 56,518,500 |
Insider trading activities including stock purchases, stock sales, and option exercises of ESPR listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Esperion Therapeutics, Inc. (symbol ESPR, CIK number 1434868) see the Securities and Exchange Commission (SEC) website.